NRP1 and cancer: Meanwhile, the mRNA expression of NRP1 was significantly down-regulated in five cancer types, including breast invasive carcinoma (BRCA), lung squamous cell carcinoma (LUSC), uterine corpus endometrial carcinoma (UCEC), kidney chromophobe (KICH), and colon adenocarcinoma (COAD).